Resveratrol and Its Nanoformulation Attenuate Growth and the Angiogenesis of Xenograft and Orthotopic Colon Cancer Models
Cancer is a multifactorial disorder that induces mortality worldwide, and the colorectal type is the third most common cancer globally. Resveratrol (RSV) is a natural compound with an effective anticancer effect, especially against colorectal cancer, and therefore numerous studies recommended its us...
Main Authors: | Thangirala Sudha, Ali H. El-Far, Deena S. Mousa, Shaker A. Mousa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/6/1412 |
Similar Items
-
Tumor Growth Progression in Ectopic and Orthotopic Xenografts from Inflammatory Breast Cancer Cell Lines
by: Sara Caceres, et al.
Published: (2021-09-01) -
Development and optimization of orthotopic liver metastasis xenograft mouse models in uveal melanoma
by: Takahito Sugase, et al.
Published: (2020-05-01) -
Antitumor Effects of Intravenous Natural Killer Cell Infusion in an Orthotopic Glioblastoma Xenograft Murine Model and Gene Expression Profile Analysis
by: Takayuki Morimoto, et al.
Published: (2024-02-01) -
Efficacy and safety of intraperitoneally administered resveratrol against rat orthotopic ovarian cancers
by: Zhong LX, et al.
Published: (2019-07-01) -
Applications of resveratrol in the treatment of gastrointestinal cancer
by: Mohammad Roshani, et al.
Published: (2022-09-01)